Physician profile
Paul J Simon
NPI 1417908468
$444.83
in general payments reported to CMS, 2019-2025
11 companies · $48.35 in 2025
The $48.35 reported for 2025 was less than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $30.95 · 2025: $48.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $48.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $48.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $146.00 | 2019-2020 | |
| Medtronic USA, INC. | $106.35 | 2019 | |
| Tempus Ai, INC | $28.03 | 2025 | Xt Cdx |
| Array Biopharma INC | $26.78 | 2019 | |
| Merck Sharp & Dohme LLC | $26.76 | 2019-2020 | |
| Celgene Corporation | $26.00 | 2019 | |
| Janssen Biotech, INC. | $25.80 | 2019 | |
| Caris Mpi, INC. | $20.32 | 2025 | Mi Cancer Seek |
| Genentech USA, INC. | $14.93 | 2019 | |
| Roche Diagnostics Corporation | $11.96 | 2019 | |
| Ortho-Clinical Diagnostics, INC. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.